These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24373858)

  • 1. Aptamer imaging with Cu-64 labeled AS1411: preliminary assessment in lung cancer.
    Li J; Zheng H; Bates PJ; Malik T; Li XF; Trent JO; Ng CK
    Nucl Med Biol; 2014 Feb; 41(2):179-85. PubMed ID: 24373858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems.
    Garrison JC; Rold TL; Sieckman GL; Figueroa SD; Volkert WA; Jurisson SS; Hoffman TJ
    J Nucl Med; 2007 Aug; 48(8):1327-37. PubMed ID: 17631556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference.
    Fani M; Del Pozzo L; Abiraj K; Mansi R; Tamma ML; Cescato R; Waser B; Weber WA; Reubi JC; Maecke HR
    J Nucl Med; 2011 Jul; 52(7):1110-8. PubMed ID: 21680701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved PET imaging of uPAR expression using new (64)Cu-labeled cross-bridged peptide ligands: comparative in vitro and in vivo studies.
    Persson M; Hosseini M; Madsen J; Jørgensen TJ; Jensen KJ; Kjaer A; Ploug M
    Theranostics; 2013; 3(9):618-32. PubMed ID: 24052804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of
    Fonseca Cabrera GO; Ma X; Lin W; Zhang T; Zhao W; Pan L; Li X; Barnhart TE; Aluicio-Sarduy E; Deng H; Wu X; Rakesh KP; Li Z; Engle JW; Wu Z
    J Nucl Med; 2024 Aug; 65(8):1250-1256. PubMed ID: 38871388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography based analysis of long-circulating cross-linked triblock polymeric micelles in a U87MG mouse xenograft model and comparison of DOTA and CB-TE2A as chelators of copper-64.
    Jensen AI; Binderup T; Kumar EK P; Kjær A; Rasmussen PH; Andresen TL
    Biomacromolecules; 2014 May; 15(5):1625-33. PubMed ID: 24645913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator.
    Sprague JE; Peng Y; Sun X; Weisman GR; Wong EH; Achilefu S; Anderson CJ
    Clin Cancer Res; 2004 Dec; 10(24):8674-82. PubMed ID: 15623652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor targeting with a (99m)Tc-labeled AS1411 aptamer in prostate tumor cells.
    Noaparast Z; Hosseinimehr SJ; Piramoon M; Abedi SM
    J Drug Target; 2015; 23(6):497-505. PubMed ID: 25673264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments.
    Boyle AJ; Cao PJ; Hedley DW; Sidhu SS; Winnik MA; Reilly RM
    Nucl Med Biol; 2015 Feb; 42(2):71-7. PubMed ID: 25456837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo evaluation of ⁶⁴Cu-radiolabeled KCCYSL peptides for targeting epidermal growth factor receptor-2 in breast carcinomas.
    Kumar SR; Gallazzi FA; Ferdani R; Anderson CJ; Quinn TP; Deutscher SL
    Cancer Biother Radiopharm; 2010 Dec; 25(6):693-703. PubMed ID: 21204764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two cross-bridged macrocyclic chelators for the evaluation of 64Cu-labeled-LLP2A, a peptidomimetic ligand targeting VLA-4-positive tumors.
    Jiang M; Ferdani R; Shokeen M; Anderson CJ
    Nucl Med Biol; 2013 Feb; 40(2):245-51. PubMed ID: 23265977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel (64)Cu- and (68)Ga-labeled RGD conjugates show improved PET imaging of α(ν)β(3) integrin expression and facile radiosynthesis.
    Dumont RA; Deininger F; Haubner R; Maecke HR; Weber WA; Fani M
    J Nucl Med; 2011 Aug; 52(8):1276-84. PubMed ID: 21764795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 64Cu-labeled 2-(diphenylphosphoryl)ethyldiphenylphosphonium cations as highly selective tumor imaging agents: effects of linkers and chelates on radiotracer biodistribution characteristics.
    Yang CT; Kim YS; Wang J; Wang L; Shi J; Li ZB; Chen X; Fan M; Li JJ; Liu S
    Bioconjug Chem; 2008 Oct; 19(10):2008-22. PubMed ID: 18763821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chelator boosted tumor-retention and pharmacokinetic properties: development of
    Zhang T; Ma X; Xu M; Cai J; Cai J; Cao Y; Zhang Z; Ji X; He J; Cabrera GOF; Wu X; Zhao W; Wu Z; Xie J; Li Z
    Eur J Nucl Med Mol Imaging; 2024 Sep; 51(11):3322-3333. PubMed ID: 38771516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of [64Cu]Cu-DOTA and [64Cu]Cu-CB-TE2A chelates for targeted positron emission tomography with an alphavbeta6-specific peptide.
    Hausner SH; Kukis DL; Gagnon MK; Stanecki CE; Ferdani R; Marshall JF; Anderson CJ; Sutcliffe JL
    Mol Imaging; 2009; 8(2):111-21. PubMed ID: 19397856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (64)Cu-labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity.
    Wei L; Ye Y; Wadas TJ; Lewis JS; Welch MJ; Achilefu S; Anderson CJ
    Nucl Med Biol; 2009 Apr; 36(3):277-85. PubMed ID: 19324273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of [⁶⁴Cu]-DOTA-PR81 radioimmunoconjugate for MUC-1 positive PET imaging.
    Alirezapour B; Rasaee MJ; Jalilian AR; Rajabifar S; Mohammadnejad J; Paknejad M; Maadi E; Moradkhani S
    Nucl Med Biol; 2016 Jan; 43(1):73-80. PubMed ID: 26453525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of copper-64-labeled somatostatin agonists and antagonist in SSTr2-transfected cell lines that are positive and negative for p53: implications for cancer therapy.
    Nguyen K; Parry JJ; Rogers BE; Anderson CJ
    Nucl Med Biol; 2012 Feb; 39(2):187-97. PubMed ID: 22056254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 111In-LLP2A-DOTA Polyethylene Glycol-Targeting {alpha}4{beta}1 Integrin: Comparative Pharmacokinetics for Imaging and Therapy of Lymphoid Malignancies.
    Denardo SJ; Liu R; Albrecht H; Natarajan A; Sutcliffe JL; Anderson C; Peng L; Ferdani R; Cherry SR; Lam KS
    J Nucl Med; 2009 Apr; 50(4):625-34. PubMed ID: 19289419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.